Picture of ATTANA AB logo

ATANA ATTANA AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Attana To Collaborate With Prof. Salanti In Developing Vaccine Against Coronavirus

March 16 (Reuters) - Attana AB  ATANA.NGM :
    * ATTANA AB WILL SUPPORT AND COLLABORATE WITH PROF. SALANTI
IN
DEVELOPING A VACCINE AGAINST CORONAVIRUS
    * CONSORTIUM WILL BASE PROJECT ON THEIR PREVIOUSLY DEVELOPED
METHOD FOR VACCINE DEVELOPMENT
    * GRANT WILL BE USED TO DEVELOP A VACCINE AGAINST NEW TYPE
OF
CORONAVIRUS DISEASE, COVID-19, WHICH AT MOMENT IS SPREADING
WORLDWIDE
    * IN COLLABORATION WITH UNIVERSITY OF TÜBINGEN, LEIDEN
UNIVERSITY
MEDICAL CENTER, WAGENINGEN UNIVERSITY AND COMPANIES ADAPTVAC AND
EXPRES2ION, RESEARCHERS FROM UNIVERSITY OF COPENHAGEN HAVE
RECEIVED A GRANT FROM EU OF EUR 2.7 MILLION

Source text for Eikon:  ID:nWkr7kl4GK 
Further company coverage:  ATANA.NGM 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on ATTANA AB

See all news